In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| 10-K | 10-K | 10-K | 10-K/A | 10-K |
Revenues: |
UNITED STATES | 54.1 | 29.6 | | | |
Government Contracts Concentration Risk | 53.2 | 29.4 | 17.1 | | |
Other | | | 4.0 | | |
Total revenues | 65.4 | 34.1 | 21.1 | -0.6 | 0.0 |
Revenue growth [+] | 91.7% | 61.3% | -3869.4% | | |
UNITED STATES | 82.9% | | | | |
Government Contracts Concentration Risk | 81.0% | 71.9% | | | |
Cost of goods sold | 35.8 | 34.7 | 23.9 | -0.3 | 0.0 |
Gross profit | 29.5 | -0.7 | -2.7 | -0.3 | 0.0 |
Gross margin | 45.2% | -1.9% | -12.9% | 47.1% | |
Selling, general and administrative | 79.7 | 86.7 | 28.6 | | |
Research and development | 0.7 | 0.1 | 0.3 | | |
Equity in earnings | 2.1 | 1.0 | -1.0 | | |
EBITDA [+] | -48.8 | -86.4 | -32.5 | | |
EBITDA growth | -43.5% | 165.5% | 12211.5% | 12042.7% | |
EBITDA margin | -74.7% | -253.5% | -154.0% | 47.1% | |
Depreciation | 35.1 | 12.9 | 8.4 | | |
EBITA | -83.9 | -99.3 | -40.9 | -0.3 | 0.0 |
EBITA margin | -128.3% | -291.4% | -193.7% | 47.1% | |
Amortization of intangibles | 0.6 | 1.4 | 1.4 | | |
EBIT [+] | -84.5 | -100.7 | -42.3 | -0.3 | 0.0 |
EBIT growth | -16.1% | 137.8% | 15919.9% | 12042.7% | |
EBIT margin | -129.2% | -295.5% | -200.4% | 47.1% | |
Non-recurring items [+] | | 18.4 | | | |
Asset impairment | | 18.4 | | | |
Interest expense, net [+] | 4.3 | 5.2 | 5.2 | | |
Interest expense | 5.4 | 5.2 | 5.2 | | |
Interest income | 1.1 | | | | |
Other income (expense), net [+] | 13.9 | -119.7 | -0.2 | -6.9 | |
Gain (loss) on debt retirement | | 4.1 | 0.3 | | |
Unrealized gain/loss on derivatives | 11.8 | 23.9 | -0.6 | | |
Change in fair value of warrants | 11.8 | 23.9 | -0.6 | -7.0 | |
Other | 2.1 | -147.7 | 0.1 | | |
Pre-tax income | -74.9 | -244.0 | -47.7 | -7.1 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | | 0.0% |
Net income | -74.2 | -245.6 | -19.5 | -7.2 | 0.0 |
Net margin | -113.5% | -720.7% | -92.4% | 1285.8% | |
|
Basic EPS [+] | ($0.64) | ($3.37) | ($1.45) | ($0.92) | $0.00 |
Growth | -81.1% | 132.9% | 56.7% | 349536.0% | |
Diluted EPS [+] | ($0.64) | ($3.37) | ($1.45) | ($0.92) | $0.00 |
Growth | -81.1% | 132.9% | 56.7% | 349536.0% | |
|
Shares outstanding (basic) [+] | 117.8 | 72.5 | 33.0 | 7.8 | 8.3 |
Growth | 62.6% | 119.5% | 322.4% | -5.3% | |
Shares outstanding (diluted) [+] | 117.8 | 72.5 | 33.0 | 7.8 | 8.3 |
Growth | 62.6% | 119.5% | 322.4% | -5.3% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |